Table 1.
Clinical characteristics of collected human samples
| Patient ID | Maternal SARS-CoV-2 status | Gender | Gestational age at infection | Gestational age at termination | Maternal age (years) | Fever | Fever temperature (°C) | Fever duration (days) | Vaccination | Vaccination dose | Height (cm) | Weight (kg) | BMI | Diastolic blood pressure (mm Hg) | Systolic blood pressure (mm Hg) | PLT (109/L) | WBC (109/L) | HGB (g/L) | HCG (mIU/mL) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P1 | maternal exposed (CoV) | female | 4 weeks | 11 weeks | 32 | yes | 37.8 | 3 | yes | 3 | 174 | 69.0 | 22.79 | 80 | 108 | 213 | 7.28 | 118 | 111,592.1 |
| P2 | maternal exposed (CoV) | female | 3 weeks | 11 weeks | 32 | no | N/A | N/A | yes | 2 | 156 | 45.0 | 18.49 | 86 | 123 | 324 | 8.00 | 141 | 68,704.8 |
| P3 | maternal exposed (CoV) | female | 3 weeks | 11 weeks | 24 | yes | 38.0 | 4 | yes | 2 | 160 | 65.0 | 25.39 | 71 | 109 | 243 | 10.52 | 131 | 181,543.9 |
| P4 | maternal exposed (CoV) | female | 4 days | 12 weeks | 33 | no | N/A | N/A | yes | 3 | 155 | 65.0 | 27.06 | 82 | 107 | 236 | 7.38 | 122 | 84,276.4 |
| P5 | maternal exposed (CoV) | female | 5 weeks | 13 weeks | 37 | yes | 39.0 | 3 | yes | 3 | 165 | 60.0 | 22.04 | 77 | 118 | 239 | 8.84 | 122 | 140,303.6 |
| P6 | maternal exposed (CoV) | female | 2 weeks | 13 weeks | 27 | yes | 38.3 | 2 | yes | 3 | 165 | 47.5 | 17.45 | 67 | 91 | 271 | 6.09 | 98 | 154,133.6 |
| P7 | maternal exposed (CoV) | female | 5 weeks | 15 weeks | 29 | no | N/A | N/A | yes | 2 | 158 | 60.0 | 24.03 | 78 | 108 | 221 | 5.40 | 118 | 19,092.7 |
| P8 | uninfected (Ctrl) | female | N/A | 11 weeks | 36 | N/A | N/A | N/A | yes | 2 | 158 | 50.0 | 20.03 | 81 | 120 | 224 | 9.72 | 109 | 200,000.0 |
| P9 | uninfected (Ctrl) | female | N/A | 11 weeks | 41 | N/A | N/A | N/A | yes | 3 | 172 | 62.0 | 20.96 | 76 | 119 | 240 | 9.89 | 132 | N/A |
| P10 | uninfected (Ctrl) | female | N/A | 12 weeks | 20 | N/A | N/A | N/A | yes | 3 | 158 | 53.0 | 21.23 | 83 | 120 | 241 | 7.35 | 124 | 174,575.9 |
| P11 | uninfected (Ctrl) | female | N/A | 14 weeks | 25 | N/A | N/A | N/A | no | N/A | 165 | 62.4 | 22.92 | 89 | 107 | 198 | 10.21 | 118 | 136,718.1 |
| P12 | uninfected (Ctrl) | female | N/A | 16 weeks | 25 | N/A | N/A | N/A | yes | 3 | 160 | 65.0 | 25.39 | 76 | 114 | 238 | 9.07 | 121 | 77,850.1 |
| P13 | maternal exposed (CoV) | male | 4 weeks | 10 weeks | 32 | yes | 40.0 | 3 | yes | 2 | 150 | 42.0 | 18.67 | 66 | 101 | 254 | 7.89 | 99 | 180,866.2 |
| P14 | maternal exposed (CoV) | male | 2 weeks | 11 weeks | 38 | yes | 39.4 | 3 | yes | 2 | 150 | 44.0 | 19.56 | 75 | 114 | 195 | 6.39 | 138 | 163,319.6 |
| P15 | maternal exposed (CoV) | male | 4 weeks | 11 weeks | 21 | yes | 39.0 | 4 | yes | 3 | 163 | 60.0 | 22.58 | 67 | 107 | 224 | 8.00 | 118 | 126,999.5 |
| P16 | maternal exposed (CoV) | male | 7 weeks | 11 weeks | 20 | yes | 38.5 | 1 | yes | 2 | 165 | 44.0 | 16.16 | 83 | 110 | 201 | 6.40 | 120 | 97,487.4 |
| P17 | maternal exposed (CoV) | male | 3 weeks | 12 weeks | 26 | yes | 38.5 | 1 | yes | 2 | 155 | 50.0 | 20.81 | 82 | 122 | 285 | 8.41 | 128 | 153,622.8 |
| P18 | maternal exposed (CoV) | male | 2 weeks | 12 weeks | 28 | no | N/A | N/A | yes | 3 | 163 | 66.0 | 24.84 | 70 | 115 | 218 | 8.85 | 136 | 186,653.3 |
| P19 | maternal exposed (CoV) | male | 5 weeks | 13 weeks | 24 | yes | 39.0 | 3 | yes | 2 | 168 | 65.0 | 23.03 | 72 | 114 | 232 | 8.26 | 131 | 93,570.9 |
| P20 | maternal exposed (CoV) | male | 5 weeks | 14 weeks | 30 | yes | 37.8 | 2 | yes | 3 | 164 | 54.0 | 20.08 | 79 | 106 | 213 | 7.90 | 145 | 146,567.5 |
| P21 | maternal exposed (CoV) | male | 5 weeks | 15 weeks | 40 | yes | 38.6 | 4 | yes | 3 | 170 | 65.0 | 22.49 | 74 | 124 | 200 | 12.54 | 134 | 100,650.6 |
| P22 | maternal exposed (CoV) | male | 2 weeks | 15 weeks | 34 | yes | 38.5 | 3 | yes | 2 | 163 | 64.0 | 24.09 | 69 | 121 | 184 | 3.46 | 93 | 57,492.4 |
| P23 | maternal exposed (CoV) | male | 9 weeks | 17 weeks | 33 | no | N/A | N/A | yes | 2 | 162 | 70.0 | 26.67 | 76 | 120 | 251 | 8.46 | 132 | N/A |
| P24 | uninfected (Ctrl) | male | N/A | 10 weeks | 29 | N/A | N/A | N/A | no | N/A | 164 | 50.0 | 18.59 | 62 | 103 | 277 | 13.83 | 127 | 160,176.9 |
| P25 | uninfected (Ctrl) | male | N/A | 12 weeks | 20 | N/A | N/A | N/A | yes | 2 | 163 | 56.0 | 21.08 | 73 | 97 | 280 | 9.01 | 126 | 137,382.8 |
| P26 | uninfected (Ctrl) | male | N/A | 12 weeks | 35 | N/A | N/A | N/A | yes | 3 | 168 | 56.0 | 19.84 | 74 | 112 | 199 | 7.69 | 113 | 58,758.5 |
| P27 | uninfected (Ctrl) | male | N/A | 11 weeks | 36 | N/A | N/A | N/A | no | N/A | 161 | 65.0 | 25.10 | 75 | 106 | 196 | 6.51 | 135 | 187,660.0 |
| P28 | uninfected (Ctrl) | male | N/A | 11 weeks | 40 | N/A | N/A | N/A | yes | 3 | 160 | 50.0 | 19.50 | 69 | 96 | 180 | 7.88 | 109 | 162,633.7 |
| P29 | uninfected (Ctrl) | female | N/A | 13 weeks | 42 | N/A | N/A | N/A | yes | 3 | 160 | 50.0 | 19.50 | 80 | 122 | 183 | 6.78 | 125 | 150,265.8 |
N/A, not available; BMI, body mass index; PLT, platelet count; WBC, white blood cell count; HGB, hemoglobin; HCG, human chorionic gonadotropin. Routine blood tests are performed at the time of elective termination.